dr. goy the evolution of treatment in relapsed/refractory mcl
Published 4 years ago • 59 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:02
dr. goy on the progression of mcl treatment
-
1:05
dr. goy on combinations with novel agents in relapsed/refractory mcl
-
1:34
dr. goy on the evolution of treatment in mantle cell lymphoma
-
0:55
dr. wang on the evolution of treatment in mcl
-
30:21
35: dr. jill interviews rachel fresco of biocidin
-
10:42
understanding mantle cell lymphoma with jia ruan, md, ph.d.
-
15:10
cell cycle regulation, part 2: the cyclin d gene
-
1:24
dr. goy on preliminary data with ibrutinib/venetoclax in relapsed/refractory mcl
-
1:08
dr. goy on advancements in relapse/refractory mantle cell lymphoma
-
1:44:18
209: resiliency radio with dr. jill: is superoxide the cause of your inflammation with bob miller
-
1:27
dr. goy on the combination of biological therapies in relapsed mcl
-
7:30
treating relapsed/refractory mantle cell lymphoma
-
4:06
identifying unmet needs in relapsed/refractory mcl
-
1:35
dr. lee on b-cell receptor targeting in relapsed/refractory mcl
-
3:51
selecting therapy for relapsed/refractory mcl
-
1:08
dr. song on zanubrutinib activity in relapsed/refractory mcl
-
1:08
dr. gerson on updates in relapsed/refractory mcl
-
1:36
dr. rule on long-term follow-up of ibrutinib monotherapy in relapsed/refractory mcl
-
7:51
relapsed/refractory mantle cell lymphoma
-
2:07
dr. wang discusses the treatment of relapsed/refractory mcl
-
1:15
dr. goy on treatment considerations in mcl